CDC Moving Forward Reorganization, 9290-9291 [2023-02929]
Download as PDF
<![CDATA[
9290
Federal Register / Vol. 88, No. 29 / Monday, February 13, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2023–02971 Filed 2–10–23; 8:45 am]
AGENCY:
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in 552b(c)(4) and
552b(c)(6), Title 5 U.S.C., as amended,
and the Determination of the Director,
Strategic Business Initiatives Unit,
Office of the Chief Operating Officer,
CDC, pursuant to Public Law 117–286.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–PS23–002, Enhancing Telehealth
Strategies to Support Retention and
Adherence to Antiretroviral Therapy
(ART) and RFA–PS23–005, Expanding
Rapid Initiation of Antiretroviral
Therapy in Non-traditional Settings:
Emergency Department.
Date: May 24–25, 2023.
Time: 10 a.m.–5 p.m. (EDT)
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1077, 8 Corporate Blvd., Atlanta, GA
30329.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, CDC, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329, Telephone: (404) 718–
8833, Email: GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics;
Notice of Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of charter renewal.
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces the renewal
of the charter of the Board of Scientific
Counselors, National Center for Health
Statistics (BSC, NCHS).
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Rebecca Hines, M.H.S., Designated
Federal Officer, Board of Scientific
Counselors, National Center for Health
Statistics, Centers for Disease Control
and Prevention, 3311 Toledo Road,
Mailstop P–08, Hyattsville, Maryland
20782; Telephone: (301) 458–4715;
Email: RSHines@cdc.gov.
CDC is
providing notice under 5 U.S.C. 1001–
1014. This charter has been renewed for
a two-year period through January 19,
2025.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUPPLEMENTARY INFORMATION:
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–02968 Filed 2–10–23; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:10 Feb 10, 2023
Jkt 259001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
CDC Moving Forward Reorganization
Centers for Disease Control and
Prevention, (CDC), Department of
Health and Human Services (HHS).
ACTION: General notice.
The Centers for Disease
Control and Prevention (CDC), an
agency within the Department of Health
and Human Services (HHS), announces
a reorganization. The CDC Director is
modernizing the agency’s organizational
structure to better position the agency to
respond to and tackle future public
health threats.
DATES: This reorganization was
approved by the Secretary of HHS on
January 24, 2023, and became effective
February 8, 2023.
FOR FURTHER INFORMATION CONTACT:
D’Artonya Graham, Office of the Chief
Operating Officer, Office of the Director,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
TW–2, Atlanta, GA 30329; Telephone
770–488–4401; Email: reorgs@cdc.gov.
SUPPLEMENTARY INFORMATION: Part C
(CDC) of the Statement of Organization,
Functions, and Delegations of Authority
of the Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, amended most
recently at 87 FR 51670–51675, dated
August 23, 2022) is amended to reflect
the reorganization of CDC. Specifically,
the changes are as follows:
Under Part C, Section C–B,
Organization and Functions, delete and/
or update functional statements for CDC
in their entirety and replace with the
following:
I. Under Part C, Section C–B,
Organization and Functions, the
following organizational units are
deleted in their entirety:
• Office of the Associate Director for
Global Health Coordination (CAE)
• Deputy Director for Public Health
Service and Implementation Science
(CB)
• Center for Global Health (CBB)
• Center for Preparedness and Response
(CBC)
• Center for State, Tribal, Local and
Territorial Support (CBD)
• Office of Minority Health and Health
Equity (CBE)
• Deputy Director for Public Health
Science and Surveillance (CP)
• Office of Science (CPP)
• Office of Laboratory Science and
Safety (CPQ)
SUMMARY:
E:\FR\FM\13FEN1.SGM
13FEN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 88, No. 29 / Monday, February 13, 2023 / Notices
• National Center for Health Statistics
(CPC)
• Center for Surveillance, Epidemiology
and Laboratory Services (CPN)
• Deputy Director for Non-Infectious
Diseases (CU)
• National Center on Birth Defects and
Developmental Disabilities (CUB)
• National Center for Chronic Disease
Prevention and Health Promotion
(CUC)
• National Center for Environmental
Health (CUG)
• National Center for Injury Prevention
and Control (CUH)
• Deputy Director for Infectious
Diseases (CV)
• National Center for Immunization and
Respiratory Diseases (CVG)
• National Center for Emerging and
Zoonotic Infectious Diseases (CVL)
• National Center for HIV, Viral
Hepatitis, STD, and TB Prevention
(CVJ)
II. Under Part C, Section C–B,
Organization and Functions, make the
following changes:
• Retitle the Office of the Director to the
Immediate Office of the Director (CA)
• Retitle the Office of the Associate
Director for Policy and Strategy to the
Office of Policy, Performance, and
Evaluation (CAQ)
• Retitle the Office of the Associate
Director for Communication to the
Office of Communications (CAU)
III. Under Part C, Section C–B,
Organization and Functions, insert the
following:
• Office of Readiness and Response
(CAD)
• Center for Forecasting and Outbreak
Analytics (CADB)
• Office of Health Equity (CAG)
• Office of Science (CAH)
• Office of Public Health Data,
Surveillance, and Technology (CAK)
• National Center for Health Statistics
(CAKB)
• Office of Laboratory Science and
Safety (CAN)
• National Center for Injury Prevention
and Control (CE)
• National Center on Birth Defects and
Developmental Disabilities (CF)
• National Center for State, Tribal,
Local, and Territorial Public Health
Infrastructure and Workforce (CH)
• National Center for Immunization and
Respiratory Diseases (CJ)
• National Center for HIV, Viral
Hepatitis, STD and TB Prevention
(CK)
• National Center for Chronic Disease
Prevention and Health Promotion (CL)
• National Center for Environmental
Health (CN)
• National Center for Emerging and
Zoonotic Infectious Diseases (CR)
VerDate Sep<11>2014
17:10 Feb 10, 2023
Jkt 259001
• Global Health Center (CW)
Delegations of Authority
All delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Dated: February 7, 2023.
Xavier Becerra,
Secretary, Department of Health and Human
Services.
[FR Doc. 2023–02929 Filed 2–10–23; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–23–0728]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘National
Notifiable Diseases Surveillance System
(NNDSS)’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on November
16, 2022 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
9291
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Notifiable Diseases
Surveillance System (OMB Control No.
0920–0728, Exp. 7/31/2025)—
Revision—Center for Surveillance,
Epidemiology and Laboratory Services
(CSELS), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42
U.S.C. 241) authorizes CDC to
disseminate nationally notifiable
condition information. The National
Notifiable Diseases Surveillance System
(NNDSS) is based on data collected at
the state, territorial and local levels as
a result of legislation and regulations in
those jurisdictions that require health
care providers, medical laboratories,
and other entities to submit healthrelated data on reportable conditions to
public health departments. These
reportable conditions, which include
infectious and non-infectious diseases,
vary by jurisdiction depending upon
each jurisdiction’s health priorities and
needs. Each year, the Council of State
and Territorial Epidemiologists (CSTE),
supported by CDC, determines which
reportable conditions should be
designated nationally notifiable or
under standardized surveillance.
CDC requests a three-year approval for
a Revision for the NNDSS. This
Revision includes requests for approval
to: (1) receive case notification data for
Carbapenemase-Producing Organisms
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 88, Number 29 (Monday, February 13, 2023)]
[Notices]
[Pages 9290-9291]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02929]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
CDC Moving Forward Reorganization
AGENCY: Centers for Disease Control and Prevention, (CDC), Department
of Health and Human Services (HHS).
ACTION: General notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), an
agency within the Department of Health and Human Services (HHS),
announces a reorganization. The CDC Director is modernizing the
agency's organizational structure to better position the agency to
respond to and tackle future public health threats.
DATES: This reorganization was approved by the Secretary of HHS on
January 24, 2023, and became effective February 8, 2023.
FOR FURTHER INFORMATION CONTACT: D'Artonya Graham, Office of the Chief
Operating Officer, Office of the Director, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, MS TW-2, Atlanta, GA 30329;
Telephone 770-488-4401; Email: [email protected].
SUPPLEMENTARY INFORMATION: Part C (CDC) of the Statement of
Organization, Functions, and Delegations of Authority of the Department
of Health and Human Services (45 FR 67772-76, dated October 14, 1980,
and corrected at 45 FR 69296, October 20, 1980, amended most recently
at 87 FR 51670-51675, dated August 23, 2022) is amended to reflect the
reorganization of CDC. Specifically, the changes are as follows:
Under Part C, Section C-B, Organization and Functions, delete and/
or update functional statements for CDC in their entirety and replace
with the following:
I. Under Part C, Section C-B, Organization and Functions, the
following organizational units are deleted in their entirety:
Office of the Associate Director for Global Health
Coordination (CAE)
Deputy Director for Public Health Service and Implementation
Science (CB)
Center for Global Health (CBB)
Center for Preparedness and Response (CBC)
Center for State, Tribal, Local and Territorial Support (CBD)
Office of Minority Health and Health Equity (CBE)
Deputy Director for Public Health Science and Surveillance
(CP)
Office of Science (CPP)
Office of Laboratory Science and Safety (CPQ)
[[Page 9291]]
National Center for Health Statistics (CPC)
Center for Surveillance, Epidemiology and Laboratory Services
(CPN)
Deputy Director for Non-Infectious Diseases (CU)
National Center on Birth Defects and Developmental
Disabilities (CUB)
National Center for Chronic Disease Prevention and Health
Promotion (CUC)
National Center for Environmental Health (CUG)
National Center for Injury Prevention and Control (CUH)
Deputy Director for Infectious Diseases (CV)
National Center for Immunization and Respiratory Diseases
(CVG)
National Center for Emerging and Zoonotic Infectious Diseases
(CVL)
National Center for HIV, Viral Hepatitis, STD, and TB
Prevention (CVJ)
II. Under Part C, Section C-B, Organization and Functions, make the
following changes:
Retitle the Office of the Director to the Immediate Office of
the Director (CA)
Retitle the Office of the Associate Director for Policy and
Strategy to the Office of Policy, Performance, and Evaluation (CAQ)
Retitle the Office of the Associate Director for Communication
to the Office of Communications (CAU)
III. Under Part C, Section C-B, Organization and Functions, insert
the following:
Office of Readiness and Response (CAD)
Center for Forecasting and Outbreak Analytics (CADB)
Office of Health Equity (CAG)
Office of Science (CAH)
Office of Public Health Data, Surveillance, and Technology
(CAK)
National Center for Health Statistics (CAKB)
Office of Laboratory Science and Safety (CAN)
National Center for Injury Prevention and Control (CE)
National Center on Birth Defects and Developmental
Disabilities (CF)
National Center for State, Tribal, Local, and Territorial
Public Health Infrastructure and Workforce (CH)
National Center for Immunization and Respiratory Diseases (CJ)
National Center for HIV, Viral Hepatitis, STD and TB
Prevention (CK)
National Center for Chronic Disease Prevention and Health
Promotion (CL)
National Center for Environmental Health (CN)
National Center for Emerging and Zoonotic Infectious Diseases
(CR)
Global Health Center (CW)
Delegations of Authority
All delegations and redelegations of authority made to officials
and employees of affected organizational components will continue in
them or their successors pending further redelegation, provided they
are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Dated: February 7, 2023.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2023-02929 Filed 2-10-23; 8:45 am]
BILLING CODE 4160-18-P
